Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Understanding Verisk Analytics (VRSK) Stock – Key Information for Investors

Shares of Industrials sector company Verisk Analytics moved 2.4% today, and are now trading at a price of $213.09. The Large-Cap stock's daily volume was 367,211 compared to its average volume of 1,263,018. The S&P 500 index returned a -0.0% performance.

Verisk Analytics, Inc. engages in the provision of data analytics and technology solutions to the insurance industry in the United States and internationally. The company is based in Jersey City and has 7,800 full time employees. Its market capitalization is $29,772,562,432. Verisk Analytics currently offers its equity investors a dividend that yields 0.2% per year.

17 analysts are following Verisk Analytics and have set target prices ranging from $220.0 to $315.0 per share. On average, they have given the company a rating of buy. At today's prices, VRSK is trading -18.17% away from its average analyst target price of $260.41 per share.

Over the last year, VRSK shares have gone down by -24.3%, which represents a difference of -45.1% when compared to the S&P 500. The stock's 52 week high is $322.92 per share and its 52 week low is $197.0. With average free cash flows of $830.55 Million that have been growing at an average rate of 3.3% over the last 5 years, Verisk Analytics declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 1,144,000 223,900 920,100 10.76
2023 1,060,700 230,000 830,700 5.92
2022 1,059,000 274,700 784,300 -11.61
2021 1,155,700 268,400 887,300 8.02
2020 1,068,200 246,800 821,400 11.08
2019 956,300 216,800 739,500
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS